cor2ed
engage checkpoint medical linkedin twitter
bg

Surveillance and novel risk factors for HCC

Surveillance and novel risk factors for HCC

Dr Walid Ayoub

Dr Walid Ayoub discusses recent data on surveillance and novel risk factors for hepatocellular carcinoma (HCC).

Portrait of Walid Ayoub
Dr Walid Ayoub

Gastroenterologist

Cedars-Sinai Medical Center

United States (US)

preview next

time | open 5 min | May 2020

download resources

This programme was made for you:   your opinion matters

Share your feedback in just 4 clicks and help us to continue to create the content you need.

I agree that this educational programme:

HCC CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer, AstraZeneca and from Eisai Europe Limited.

Other programmes of interest